EAGLE ASSET MANAGEMENT INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$13,367,126
-22.4%
497,474
+3.0%
0.08%
-17.7%
Q2 2023$17,222,888
+63.0%
482,975
+16.1%
0.10%
+54.8%
Q1 2023$10,566,000
-39.7%
416,005
-8.6%
0.06%
-42.1%
Q4 2022$17,521,000
+16.6%
454,994
+0.1%
0.11%
+9.2%
Q3 2022$15,028,000
-15.6%
454,717
-10.0%
0.10%
-12.5%
Q2 2022$17,796,000
-27.7%
505,433
-5.6%
0.11%
-11.1%
Q1 2022$24,631,000
-28.8%
535,586
+4.2%
0.13%
-17.1%
Q4 2021$34,606,000
+7.3%
513,838
-0.6%
0.15%
+4.1%
Q3 2021$32,263,000
-32.7%
516,789
-10.7%
0.15%
-29.1%
Q2 2021$47,933,000
+19.7%
578,770
-3.0%
0.21%
+16.4%
Q1 2021$40,035,000
-22.4%
596,918
-11.2%
0.18%
-39.2%
Q4 2020$51,570,000
+58.9%
672,104
-10.1%
0.29%
+74.3%
Q3 2020$32,461,000
+7.6%
747,623
+5.6%
0.17%
-2.9%
Q2 2020$30,166,000
+48.1%
708,137
+0.0%
0.17%
+35.4%
Q1 2020$20,365,000
-54.4%
707,867
+0.5%
0.13%
-40.9%
Q4 2019$44,658,000704,0640.22%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders